Nan Fung Group Holdings »

Affimed Therapeutics B V shares owned by Nan Fung Group Holdings

Quarter-by-quarter ownership of Affimed Therapeutics B V shares owned by Nan Fung Group Holdings from 13F filings

Historical chart of Nan Fung Group Holdings investment in Affimed Therapeutics B V

Tip: Access up to 7 years of quarterly data

All positions including Affimed Therapeutics B V held by Nan Fung Group Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Affimed Therapeutics B V by Nan Fung Group Holdings

Quarter filed Position value Share count Share price at filing
2023-09-30 $178k 373k 0.48
2023-06-30 $223k 373k 0.60
2023-03-31 $278k 373k 0.75
2022-12-31 $462k 373k 1.24
2022-09-30 $167k 81k 2.06
2022-06-30 $225k 81k 2.77
2022-03-31 $355k 81k 4.37

More positions owned by Nan Fung Group Holdings

Karuna Therapeutics Ord
Illumina (ILMN)
Harmony Biosciences Hldgs In (HRMY)
Seagen
Oculis Holding Ordinary Shares (OCS)
Somalogic Class A Com
Exscientia Ads (EXAI)
Xenon Pharmaceuticals (XENE)
Merus N V (MRUS)
Replimune Group (REPL)
Kalvista Pharmaceuticals (KALV)
Beigene Sponsored Adr (BGNE)
Alpine Immune Sciences (ALPN)
Incyte Corporation (INCY)
Geron Corporation (GERN)

View all positions for Nan Fung Group Holdings

Top funds holding Affimed Therapeutics B V

IFP Advisors
Cape Investment Advisory

View all funds holding Affimed Therapeutics B V